CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
002581 Shandong Sinobioway Biomedicine
- 6.61
- +0.60+9.98%
Market Closed Apr 30 15:00 CST
4.36BMarket Cap-29.77P/E (TTM)
6.61High5.69Low429.47KlotVolume5.69Open6.01Pre Close269.79MTurnover10.72%Turnover RatioLossP/E (Static)659.74MShares14.4352wk High2.31P/B2.65BFloat Cap5.6952wk Low6.61Limit Up400.79MShs Float71.85Historical High5.41Limit Down15.31%Amplitude4.39Historical Low--Dividend TTM6.28Avg Price138.31KlotAsk--Div YieldTTM100Lot Size268.78KlotBid
Shandong Sinobioway Biomedicine Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 106.63%445.01M | 233.35%506.4M | 22.26%388.85M | 366.27%394.39M | 93.91%215.36M | -17.35%151.91M | 124.33%318.05M | -42.34%84.58M | -30.24%111.07M | -2.13%183.8M |
| Transactional financial assets | ---- | ---- | --40M | --40M | ---- | --0 | --0 | --0 | ---- | ---- |
| Notes receivable and accounts receivable | -46.84%67.97M | -41.50%87.21M | -22.47%124.26M | -15.00%150.95M | -11.17%127.86M | -15.49%149.08M | -16.21%160.27M | -21.45%177.59M | -41.86%143.94M | -32.61%176.41M |
| -Notes receivable | 73.26%10.63M | -8.27%14.16M | 9.15%7.95M | -48.86%5.69M | -31.63%6.14M | 65.44%15.43M | --7.29M | 97.60%11.14M | -33.71%8.97M | -8.25%9.33M |
| -Accounts receivable | -52.90%57.34M | -45.34%73.06M | -23.98%116.3M | -12.73%145.26M | -9.81%121.73M | -20.01%133.64M | -20.02%152.98M | -24.49%166.46M | -42.34%134.96M | -33.59%167.08M |
| Other receivables (including interest and dividends) | 91.55%101.18M | -33.26%51.22M | -6.16%53.48M | -3.02%52.76M | 806.47%52.82M | 372.18%76.74M | 278.18%56.99M | 252.70%54.41M | -61.48%5.83M | 20.49%16.25M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --276.02K | ---- | --1.04M |
| -Other receivable | ---- | ---- | ---- | -2.53%52.76M | ---- | --76.74M | --56.99M | 250.91%54.13M | ---- | ---- |
| Contractual assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Advance payment | 67.49%10.95M | 117.33%10.21M | 10.18%9.78M | -13.81%2.97M | -72.18%6.54M | -79.53%4.7M | -67.77%8.88M | -88.80%3.44M | -13.35%23.51M | 10.92%22.94M |
| Inventories | 2.71%87.71M | -6.65%79.64M | -10.54%81.08M | -12.65%78.92M | -4.93%85.39M | 6.58%85.31M | 17.95%90.63M | 3.26%90.35M | 24.76%89.82M | 24.42%80.04M |
| Receivable financing | -51.00%7.97M | -74.08%6.1M | -25.42%20.16M | -10.96%17.73M | -15.46%16.27M | 610.71%23.55M | 355.58%27.03M | 281.44%19.91M | 113.24%19.24M | -70.40%3.31M |
| Assets held for sale | ---- | ---- | 0.00%928.82K | 0.00%928.82K | 0.00%928.82K | -96.07%928.82K | 0.00%928.82K | 0.00%928.82K | 0.00%928.82K | 2,443.33%23.62M |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | ---- |
| Other current assets | 170.97%9.09M | 38.57%6.22M | -76.22%3.36M | -72.12%3.62M | -70.37%3.35M | -62.48%4.49M | 3,933.97%14.12M | 300.06%13M | 42.40%11.32M | 44.92%11.97M |
| Total current assets | 43.53%729.88M | 50.39%747.01M | 6.65%721.88M | 67.10%742.27M | 25.36%508.53M | -4.18%496.71M | 47.25%676.9M | -13.89%444.2M | -24.73%405.65M | -8.81%518.36M |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other debt investment | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other equity investment | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Investment real estate | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Long-term equity investment | -18.94%1.05B | -22.06%1.06B | -12.91%1.14B | -26.21%1.09B | -13.48%1.29B | -9.85%1.35B | -11.09%1.31B | 10.67%1.48B | 18.22%1.5B | 21.65%1.5B |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Fixed assets | ---- | ---- | ---- | -49.10%292.68M | ---- | --334.89M | ---- | 9.19%574.98M | ---- | ---- |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | --262K | ---- | ---- | ---- | ---- |
| Constru in process | ---- | ---- | ---- | -76.92%21.02M | ---- | --22.17M | ---- | 8.57%91.06M | ---- | ---- |
| Productive biological assets | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Oil and gas assets | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Intangible assets | -13.83%91.65M | -13.68%93.47M | -14.60%102.44M | -14.46%104.4M | -14.35%106.36M | -14.28%108.29M | -6.34%119.95M | -6.23%122.05M | -6.08%124.18M | -5.93%126.32M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Goodwill | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Long deferred expense | -73.20%284.5K | -77.11%323.09K | -91.25%361.68K | -85.16%711.53K | -79.25%1.06M | -72.84%1.41M | -28.64%4.13M | -25.72%4.8M | -28.15%5.12M | -33.24%5.2M |
| Deferred tax assets | 119.82%12.85M | 83.04%11.21M | -40.71%5.71M | -52.05%5.88M | -49.07%5.84M | -46.64%6.12M | -56.09%9.63M | -40.39%12.27M | -49.41%11.47M | -54.61%11.47M |
| Usufruct assets | 608.85%4.14M | -66.10%262.2K | -65.28%303.6K | -59.47%394.37K | -59.31%583.86K | -99.10%773.36K | -98.99%874.53K | -98.91%972.95K | -98.43%1.43M | -8.61%85.6M |
| Other non current assets | -10.64%11.66M | 12.00%13.44M | -42.59%13.98M | -43.52%13.68M | -60.25%13.05M | 2,342.20%12M | -71.69%24.35M | -71.02%24.22M | -60.59%32.82M | -99.41%491.34K |
| Total non current assets | -17.71%1.44B | -21.27%1.45B | -25.83%1.57B | -33.76%1.53B | -25.94%1.75B | -21.73%1.84B | -11.87%2.12B | 1.43%2.31B | 6.36%2.36B | 6.91%2.35B |
| Total assets | -3.91%2.17B | -6.04%2.2B | -17.98%2.3B | -17.46%2.27B | -18.41%2.26B | -18.56%2.34B | -2.39%2.8B | -1.41%2.75B | 0.28%2.77B | 3.68%2.87B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -77.02%2.3M | -80.01%2.77M | --0 | -93.56%10M | -93.20%10M | -90.80%13.84M | -29.95%117.2M | -7.33%155.23M | -12.24%147M | -0.74%150.42M |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Notes payable and accounts payable | -29.81%25.89M | -52.03%35.35M | -24.60%35.66M | -24.61%35.1M | 9.02%36.89M | 68.87%73.69M | 30.92%47.29M | -23.88%46.55M | -31.34%33.84M | 3.57%43.64M |
| -Notes payable | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Accounts payable | -29.81%25.89M | -52.03%35.35M | -24.60%35.66M | -24.61%35.1M | 9.02%36.89M | 68.87%73.69M | 30.92%47.29M | -23.88%46.55M | -31.34%33.84M | 3.57%43.64M |
| Contract liabilities | 990.18%27.25M | 191.36%10.46M | 135.68%6.1M | 62.99%5.71M | 11.53%2.5M | -86.64%3.59M | -39.02%2.59M | -23.36%3.51M | -34.18%2.24M | 683.63%26.86M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --750.5K | ---- |
| Salaries payable | 0.22%4.62M | -15.76%11.41M | 7.96%7.95M | -39.48%4.85M | -48.97%4.61M | 0.54%13.54M | -12.83%7.37M | 2.52%8.01M | 11.93%9.03M | -32.89%13.47M |
| Taxs payable | -33.07%1.78M | -48.73%2.36M | -15.29%4.41M | 14.38%4.88M | -31.74%2.66M | -26.94%4.61M | -25.87%5.21M | -63.53%4.27M | -52.38%3.9M | -16.61%6.31M |
| Other payable (including interest and dividends) | 74.67%29.2M | -15.24%18.03M | -86.81%10.43M | -69.99%25.7M | -82.59%16.72M | -78.55%21.27M | 4.04%79.11M | 1,226.04%85.65M | 1,381.13%96.02M | 541.12%99.16M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | --1.38M |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| -Other payable | ---- | ---- | ---- | -69.99%25.7M | ---- | --21.27M | --79.11M | 1,226.04%85.65M | ---- | ---- |
| Hold and for sell liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Non current liabilities due within one year | --0 | --168.94K | ---- | ---- | ---- | ---- | --0 | --0 | ---- | -14.96%13.46M |
| Other current liabilities | --0 | -32.88%2.06M | --0 | ---- | 463.47%2.47M | -72.00%3.07M | 257.10%969.48K | 1,460.59%2.36M | -82.22%438.85K | 335.04%10.97M |
| Total current liabilities | 20.03%91.04M | -38.17%82.61M | -75.15%64.55M | -71.78%86.24M | -74.13%75.84M | -63.32%133.61M | -16.99%259.74M | 16.27%305.58M | 14.95%293.22M | 40.90%364.28M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Bonds payable | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Preferred stock | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Perpetual Debt | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Long term salaries pay | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Estimate liabilities | 481.86%79.73M | 372.98%76.12M | 46.02%13.2M | 76.66%16.79M | 41.65%13.7M | 66.37%16.09M | --9.04M | --9.5M | --9.67M | --9.67M |
| Deferred tax liabilities | 40.27%10.42M | 25.11%9.39M | 7.09%7.76M | 1.43%7.43M | 2.53%7.43M | 2.54%7.51M | -14.27%7.25M | -14.15%7.32M | -15.82%7.24M | -15.68%7.32M |
| Long term deferred income | 2.01%5.49M | 0.00%5.49M | -10.87%5.17M | -13.54%5.28M | -15.96%5.39M | -18.17%5.49M | -34.26%5.8M | -33.12%6.1M | -34.17%6.41M | -31.04%6.71M |
| Lease liabilities | 675.82%4.01M | ---- | -75.59%209.43K | -68.49%320.44K | -64.91%516.76K | -51.81%709.79K | --857.86K | -89.62%1.02M | -84.97%1.47M | -84.97%1.47M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Total non current liabilities | 268.65%99.65M | 205.36%91.01M | 14.80%26.33M | 24.50%29.81M | 9.01%27.03M | 18.36%29.8M | 32.81%22.94M | -12.78%23.95M | -11.87%24.8M | -10.76%25.18M |
| Total liabilities | 85.36%190.69M | 6.24%173.61M | -67.85%90.89M | -64.78%116.06M | -67.65%102.88M | -58.04%163.41M | -14.39%282.68M | 13.52%329.52M | 12.28%318.02M | 35.82%389.46M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%229.15M | 0.00%229.15M | 0.00%229.15M | 0.00%229.15M | 0.00%229.15M | 0.00%229.15M | 0.00%229.15M | 0.00%229.15M | 0.00%229.15M | 0.00%229.15M |
| Other equity instruments | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Equity of prefer stock | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Equity of Perpetual debt | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Capital reserve funds | -1.06%871.01M | -0.86%866.41M | 1.57%881.2M | 2.05%878.38M | 2.57%880.33M | 1.80%873.93M | 1.09%867.61M | 0.29%860.75M | 0.00%858.29M | 0.00%858.5M |
| Surplus reserve funds | 0.00%152.52M | 0.00%152.52M | 0.78%152.52M | 0.78%152.52M | 0.78%152.52M | 0.00%152.52M | 0.00%151.35M | 0.00%151.35M | 0.00%151.35M | 0.00%152.52M |
| Retained profit | -18.65%638.7M | -16.89%675.55M | -28.94%827.49M | -27.54%783.25M | -29.47%785.16M | -29.03%812.87M | -4.07%1.16B | -7.87%1.08B | -3.30%1.11B | -1.27%1.15B |
| Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other composite income | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Ordinary risk reserve funds | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Specific reserves | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Shareholders equity without minority interests | -7.61%1.89B | -7.00%1.92B | -13.36%2.09B | -12.01%2.04B | -12.96%2.05B | -13.29%2.07B | -1.63%2.41B | -3.73%2.32B | -1.59%2.35B | -0.61%2.39B |
| Minority interests | -19.01%85.77M | -6.26%98.67M | 10.49%114.63M | 12.49%110.06M | 11.41%105.91M | 10.87%105.26M | 22.45%103.75M | 13.24%97.84M | 13.10%95.06M | 17.04%94.94M |
| Total shareholder equity | -8.17%1.98B | -6.97%2.02B | -12.37%2.2B | -11.02%2.15B | -12.01%2.15B | -12.36%2.17B | -0.83%2.52B | -3.14%2.42B | -1.09%2.45B | -0.03%2.48B |
| Total liabilityies and equity | -3.91%2.17B | -6.04%2.2B | -17.98%2.3B | -17.46%2.27B | -18.41%2.26B | -18.56%2.34B | -2.39%2.8B | -1.41%2.75B | 0.28%2.77B | 3.68%2.87B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion with explanatory notes |
| Auditor | -- | Shenzhen Guangshen Certified Public Accountants Firm (General Partnership) | -- | -- | -- | Shenzhen Guangshen Certified Public Accountants Firm (General Partnership) | -- | -- | -- | Shenzhen Guangshen Certified Public Accountants Firm (General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.